Paper42932136PubMed
Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine.
Koufakis T and 6 others. Adv Ther, 2026.
Cite this record
ConductScience Library. Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine. Papers, record 42932136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42932136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine.
- Journal
- Adv Ther
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-26
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32940941 | Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake. | Compr Physiol | 2020 | https://conductscience.org/library/papers/32940941 | PubMed |
| 2 | 41744761 | Decoding the Endocrine Code of Skeletal Muscle: Myokines, Exerkines, and Inter-Organ Crosstalk in Metabolic Health and Disease. | Cells | 2026 | https://conductscience.org/library/papers/41744761 | PubMed |
| 3 | 37186680 | Sarcopenia and Cardiovascular Diseases. | Circulation | 2023 | https://conductscience.org/library/papers/37186680 | PubMed |
| 4 | 41465572 | Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465572 | PubMed |
| 5 | 42183678 | Beyond sarcopenia and frailty: the underrecognised contribution of adiposity to vulnerability in older adults. | Acta Cardiol | 2026 | https://conductscience.org/library/papers/42183678 | PubMed |
| 6 | 36292489 | Approaching Sarcopenic Obesity in Young and Middle-Aged Female Adults in Weight Management Settings: A Narrative Review. | Healthcare (Basel) | 2022 | https://conductscience.org/library/papers/36292489 | PubMed |
| 7 | 32082422 | Mechanism of increased risk of insulin resistance in aging skeletal muscle. | Diabetol Metab Syndr | 2020 | https://conductscience.org/library/papers/32082422 | PubMed |
| 8 | 39796218 | Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39796218 | PubMed |
| 9 | 41354946 | Effectiveness of SGLT2 inhibitors, incretin-based therapies, and finerenone on cardiorenal outcomes: a meta-analysis and network meta-analysis. | Cardiovasc Diabetol Endocrinol Rep | 2025 | https://conductscience.org/library/papers/41354946 | PubMed |
| 10 | 36882248 | Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis. | BMJ Open | 2023 | https://conductscience.org/library/papers/36882248 | PubMed |
| 11 | 41201615 | Muscle loss and GLP-1R agonists use. | Acta Diabetol | 2026 | https://conductscience.org/library/papers/41201615 | PubMed |
| 12 | 42339604 | Effects of sodium-glucose cotransporter 2 inhibitors on body weight and metabolic parameters in obese patients with and without type 2 diabetes: a systematized narrative review. | Curr Med Res Opin | 2026 | https://conductscience.org/library/papers/42339604 | PubMed |
| 13 | 41419185 | A Meta-Analysis of Body Composition Changes Associated With Long-term Use of Sodium-Glucose Cotransporter 2 Inhibitors. | Endocr Pract | 2026 | https://conductscience.org/library/papers/41419185 | PubMed |
| 14 | 36584211 | Effect of SGLT-2 inhibitors on body composition in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. | PLoS One | 2022 | https://conductscience.org/library/papers/36584211 | PubMed |
| 15 | 34120150 | Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus. | Nutr Diabetes | 2021 | https://conductscience.org/library/papers/34120150 | PubMed |
| 16 | 39768974 | Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Body Composition and Fluid Status in Cardiovascular Rehabilitation Patients with Coronary Artery Disease and Heart Failure. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/39768974 | PubMed |
| 17 | 40630104 | SGLT2 inhibitors as metabolic modulators: beyond glycemic control in type 2 diabetes. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40630104 | PubMed |
| 18 | 40810125 | Exploring the disconnect: mechanisms underpinning the absence of physical function improvement with SGLT2 inhibitors. | Front Syst Biol | 2025 | https://conductscience.org/library/papers/40810125 | PubMed |
| 19 | 32580152 | Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use. | Endocr Connect | 2020 | https://conductscience.org/library/papers/32580152 | PubMed |
| 20 | 34854254 | Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice. | J Cachexia Sarcopenia Muscle | 2022 | https://conductscience.org/library/papers/34854254 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42932136
GET https://conductscience.org/api/papers/v1/42932136/references?page=2